Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient ...

Recursion Pharmaceuticals Inc. RXRX) on Tuesday reported a loss of $171.9 million in its second quarter. On a per-share basis, the Salt Lake City-based company said it had a loss of 41 cents.

To improve the developer experience, organizations need to remove the friction points developers face in doing their jobs.